Pustular dermatitis following treatment of seborrheic dermatitis with an erroneously compounded dithranol preparation;Pustulose Dermatitis nach anwendung einer zu hoch konzentrierten magistralen dithranolzubereitung bei seborrhoischem ekzem

Hautarzt

Volumn 49, Issue 10, 1998, Pages 781-783

  Ludolph Hauser, Dagmar ^a,b   Michelsen, Silke ^a   Korting, Hans Christian ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Compounding; Dithranol dermatitis; Dithranol treatment; Seborrhoic dermatitis

Indexed keywords

DITHRANOL; ANTIINFLAMMATORY AGENT;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DRUG ERUPTION; DRUG FORMULATION; ERROR; HUMAN; PUSTULE; SEBORRHEIC DERMATITIS; TOPICAL DRUG ADMINISTRATION; DOSE RESPONSE; MALE; MEDICATION ERROR; OINTMENT; SKIN DISEASE;

ADMINISTRATION, TOPICAL; ADULT; ANTHRALIN; ANTI-INFLAMMATORY AGENTS; DERMATITIS, SEBORRHEIC; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ERUPTIONS; FACIAL DERMATOSES; HUMANS; MALE; MEDICATION ERRORS; OINTMENTS;

EID: 0031593715     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001050050826     Document Type: Article

References (20)

1. Brandt H, Mustakallio KK (1983) Irritation and staining by dithranol (anthralin) and related compounds. III. Cumulative irritancy and staining during repeated chamber testing. Acta Derm Venereol (Stockh) 63:237-240
2. Barr RM, Miach KJ, Hensby C, Mallet AI, Greaves MV (1983) Arachidonic acid and prostaglandin levels in dithranol erythema: time course. Br J Clin Pharmacol 16:715-717
3. Braun-Falco O, Plewig G, Wolff HH (1995) Dermatologie und Venerologie, 4.Aufl. Springer, Berlin Heidelberg New York, S. 436-442
4. Braun-Falco O, Heilgemeir GP, Lincke-Plewig H (1979) Histologische Differentialdiagnose von Psoriasis vulgaris und seborrhoischen Ekzemen des Kapillitiums. Hautarzt 30:478-483
5. Fuchs J, Zimmer G, Wölbling RH, Milbradt R (1986) On the interaction between anthralin and mitochondria: a revision. Arch Dermatol Res 279:59-65
6. Garbe C, Reimann H, Sander-Bähr C (1996) Rationelle dermatologische Rezeptur. Thieme, Stuttgart; Govi, Frankfurt
7. Ippen H (1981) Basic questions on toxicology and pharmacology of anthralin. Br J Dermatol 105:72-75
8. Kammerau B, Zesch A, Schaefer H (1975) Absolute concentrations of dithranol and triacetyldithranol in the skin layers after local treatment: in vivo investigations with four different types of pharmaceutical vehicles. J Invest Dermatol 64:145-149
9. Kingston T, Marks R (1983) Irritant reactions to dithranol in normal subjects and psoriatic patients. Br J Dermatol 108:307-313
10. Korting HC (1997) Heilversuch. In: Plewig G, Przybilla B (Hrsg) Fortschritte der praktischen Dermatologie und Venerologie 1996, Bd 15. Springer, Berlin Heidelberg New York, S117-123
11. Lawlor F, Hindson C (1982) Allergy to dithranol. Contact Dermatitis 8:137-138
12. Lawrence CM, Shuster S (1983) Mechanism of anthralin inflammation. 1. Dissociation of response to clobetasol and indomethacin. Br J Dermatol 113:107-115
13. Mustakallio KK (1979) Irritation and staining by dithranol (anthralin) related compounds.I. Estimation with chamber testing and contact thermography. Acta Derm Venereol (Stckh) 59:125-126
14. Mustakallio KK (1980) Irritation and staining by dithranol (anthralin) related compounds.II. Structure-activity relationships among 10-meso-substituted acyl analogues. Acta Derm Venereol (Stockh) 60:169-171
15. Reichert U, Jaques Y, Grangeret M, Schmidt R (1985) Antirespiratory and antiproliferative activity of anthralin in cultured human keratinocytes. J Invest Dermatol 84:130-134
16. Runne U, Kunze J (1982) Short-duration ("minutes") therapy with dithranol for psoriasis: a new out-patient regimen. Br J Dermatol 105:135-139
17. Schaefer H, Farber EM, Goldberg L, Schalla W (1980) Limited application period for dithranol in psoriasis. Preliminary report on penetration and clinical efficacy. Br J Dermatol 102:571-573
18. Schalla W, Bauer E, Schaefer H (1981) Skin permeability of anthralin. Br J Dermatol 105:104-108
19. Wölbling RH, Fuchs J, Schäfer V, Milbradt R (1987) Zur Dithranol-Therapie der seborrhoischen Dermatitis. Akt Dermatol 13:301-303
20. Wölbling RH, Schäfer V, Milbradt R (1985) Die Behandlung der seborrhoischen Dermatitis mit niedrig konzentriertem Dithranol. Hautarzt 36:529-530